17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development

Jalview Version 2—a multiple sequence alignment editor and analysis workbench

Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. E., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,011 · see citing works

MAFFT version 5: improvement in accuracy of multiple sequence alignment

Katoh, K., Kuma, K., Toh, H., & Miyata, T. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki198 · Cited by 5,063 · see citing works

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B., & Prossnitz, E. R. (2005) · Science · doi:10.1126/science.1106943 · Cited by 2,302 · see citing works

ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease

Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303 · see citing works

Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082 · see citing works

Medium- and short-chain dehydrogenase/reductase gene and protein families: The SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes

Kavanagh, K. L., Jörnvall, H., Persson, B., & Oppermann, U. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8588-y · Cited by 908 · see citing works

Intracrinology

Labrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685 · see citing works

The Effect of Postmenopausal Estrogen Therapy on Bone Density in Elderly Women

Felson, D. T., Zhang, Y., Hannan, M. T., Kiel, D. P., Wilson, P. W. F., & Anderson, J. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310143291601 · Cited by 584 · see citing works

Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases

Filling, C., Berndt, K. D., Benach, J., Knapp, S., Prozorovski, T., Nordling, E., Ladenstein, R., Jörnvall, H., & Oppermann, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202160200 · Cited by 583 · see citing works

Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3

Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570 · see citing works

Molecular Endocrinology of Hydroxysteroid Dehydrogenases

Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 436 · see citing works

The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative

Persson, B., Kallberg, Y., Bray, J. E., Bruford, E. A., Dellaporta, S. L., Favia, A. D., Duarte, R. G., Jörnvall, H., Kavanagh, K. L., Kedishvili, N. Y., et al. (2008) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.10.040 · Cited by 397 · see citing works

Aldo-Keto Reductases and Bioactivation/Detoxication

Jin, Y., & Penning, T. M. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 386 · see citing works

An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease

Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379 · see citing works

Hormone Replacement Therapy in Relation to Breast Cancer

Chen, C. (2002) · JAMA · doi:10.1001/jama.287.6.734 · Cited by 360 · see citing works

Intracrinology: Role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

Labrie, F., Luu-The, V, Lin, S., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., & Belanger, A. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250001 · Cited by 278 · see citing works

Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase

Luu-The, V. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00155-2 · Cited by 245 · see citing works

Submicroscopic Duplications of the Hydroxysteroid Dehydrogenase HSD17B10 and the E3 Ubiquitin Ligase HUWE1 Are Associated with Mental Retardation

Froyen, G., Corbett, M. A., Vandewalle, J., Järvelä, I. E., Lawrence, O., Meldrum, C. J., Bauters, M., Govaerts, K., Vandeleur, L., Esch, H. V., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.11.002 · Cited by 225 · see citing works

Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenases from rat and human prostate

Biswas, M. G., & Russell, D. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15959 · Cited by 224 · see citing works

An overview on 5α-reductase inhibitors

Aggarwal, S., Thareja, S., Verma, A., Bhardwaj, T. R., & Kumar, M. (2009) · Steroids · doi:10.1016/j.steroids.2009.10.005 · Cited by 222 · see citing works

Carbonyl Reductases and Pluripotent Hydroxysteroid Dehydrogenases of the Short-chain Dehydrogenase/reductase Superfamily

Hoffmann, F., & Maser, E. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530600969440 · Cited by 220 · see citing works

Integrated view on 17beta-hydroxysteroid dehydrogenases

Moeller, G., & Adamski, J. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.040 · Cited by 214 · see citing works

Structure and function of human 17β-hydroxysteroid dehydrogenases

Lukacik, P., Kavanagh, K. L., & Oppermann, U. C. T. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.007 · Cited by 192 · see citing works

Steroid hormone transforming aldo–keto reductases and cancer

Penning, T. M., & Byrns, M. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03700.x · Cited by 181 · see citing works

Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368222 · Cited by 177 · see citing works

Characterization of Type 12 17β-Hydroxysteroid Dehydrogenase, an Isoform of Type 3 17β-Hydroxysteroid Dehydrogenase Responsible for Estradiol Formation in Women

Luu-The, V., Tremblay, P., & Labrie, F. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0058 · Cited by 172 · see citing works

Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.

LABRIE, C., BELANGER, A., & LABRIE, F. (1988) · Endocrinology · doi:10.1210/endo-123-3-1412 · Cited by 167 · see citing works

D-Glyceraldehyde-3-Phosphate Dehydrogenase: Three-Dimensional Structure and Evolutionary Significance

Buehner, M., Ford, G. C., Moras, D., Olsen, K. W., & Rossmann, M. G. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.11.3052 · Cited by 161 · see citing works

Involvement of up-regulation of 17?-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers

Miyoshi, Y., Ando, A., Shiba, E., Taguchi, T., Tamaki, Y., & Noguchi, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1525 · Cited by 148 · see citing works

Multiplicity of Mammalian Reductases for Xenobiotic Carbonyl Compounds

Matsunaga, T., Shintani, S., & Hara, A. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.1 · Cited by 148 · see citing works

Crystal structure of human estrogenic 17β-hydroxysteroid dehydrogenase complexed with 17β-estradiol

Azzi, A., Rehse, P. H., Zhu, D., Campbell, R. L., Labrie, F., & Lin, S. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-665 · Cited by 139 · see citing works

Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action

Penning, T. M. (2003) · Human Reproduction Update · doi:10.1093/humupd/dmg022 · Cited by 137 · see citing works

Xenobiotic carbonyl reduction and physiological steroid oxidoreduction

Maser, E. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00330-o · Cited by 137 · see citing works

Multiple functions of type 10 17β-hydroxysteroid dehydrogenase

Yang, S., He, X., & Schulz, H. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.03.006 · Cited by 134 · see citing works

Representation of Molecular Electrostatic Potentials by Topological Feature Maps

Gasteiger, J., Li, X., Rudolph, C., Sadowski, J., & Zupan, J. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00090a009 · Cited by 126 · see citing works

Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors

Penning, T. M., Steckelbroeck, S., Bauman, D. R., Miller, M. W., Jin, Y., Peehl, D. M., Fung, K.-M. A., & Lin, H.-K. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.009 · Cited by 125 · see citing works

Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis

Šmuc, T., Pucelj, M. R., Šinkovec, J., Husen, B., Thole, H., & Rižner, T. L. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601152219 · Cited by 124 · see citing works

Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis

Day, J. M., Tutill, H. J., Purohit, A., & Reed, M. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0042 · Cited by 123 · see citing works

Design, Synthesis, and 3D QSAR of Novel Potent and Selective Aromatase Inhibitors

Leonetti, F., Favia, A. D., Rao, A., Aliano, R., Paluszcak, A., Hartmann, R. W., & Carotti, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049535j · Cited by 122 · see citing works

The Discovery of New 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors by Common Feature Pharmacophore Modeling and Virtual Screening

Schuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 110 · see citing works

Design, Synthesis, Biological Evaluation and Pharmacokinetics of Bis(hydroxyphenyl) substituted Azoles, Thiophenes, Benzenes, and Aza-Benzenes as Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)

Bey, E., Marchais‐Oberwinkler, S., Werth, R., Negri, M., Al‐Soud, Y. A., Kruchten, P., Oster, A., Frotscher, M., Birk, B., & Hartmann, R. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006917 · Cited by 109 · see citing works

17β‐hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone‐dependent breast cancer

Day, J. M., Foster, P., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23350 · Cited by 107 · see citing works

Androgen metabolism via 17β-hydroxysteroid dehydrogenase type 3 in mammalian and non-mammalian vertebrates: comparison of the human and the zebrafish enzyme

Mindnich, R., Haller, F., Halbach, F., Moeller, G., de Angelis, M. H., & Adamski, J. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01853 · Cited by 107 · see citing works

Perfluorooctanoic Acid Effects on Steroid Hormone and Growth Factor Levels Mediate Stimulation of Peripubertal Mammary Gland Development in C57Bl/6 Mice

Zhao, Y. M., Tan, Y., Haslam, S. Z., & Yang, C. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq030 · Cited by 105 · see citing works

Characterization of Ke 6, a New 17β-Hydroxysteroid Dehydrogenase, and Its Expression in Gonadal Tissues

Fomitcheva, J., Baker, M. E., Anderson, E., Lee, G. Y., & Aziz, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22664 · Cited by 104 · see citing works

Peritoneal endometriosis: validation of an in-vivo model

Grümmer, R. (2001) · Human Reproduction · doi:10.1093/humrep/16.8.1736 · Cited by 104 · see citing works

Crystal Structure of Human ABAD/HSD10 with a Bound Inhibitor: Implications for Design of Alzheimer's Disease Therapeutics

Kissinger, C. R., Rejto, P. A., Pelletier, L. A., Thomson, J. A., Showalter, R. E., Abreo, M. A., Agree, C. S., Margosiak, S. A., Meng, J. J., Aust, R. M., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.07.071 · Cited by 103 · see citing works

Pharmacophore Modeling and in Silico Screening for New P450 19 (Aromatase) Inhibitors

Schuster, D., Laggner, C., Steindl, T. M., Palusczak, A., Hartmann, R. W., & Langer, T. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050237k · Cited by 99 · see citing works

Lead Optimization Providing a Series of Flavone Derivatives as Potent Nonsteroidal Inhibitors of the Cytochrome P450 Aromatase Enzyme

Gobbi, S., Cavalli, A., Rampa, A., Belluti, F., Piazzi, L., Paluszcak, A., Hartmann, R. W., Recanatini, M., & Bisi, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060186y · Cited by 98 · see citing works

Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity

Lukacik, P., Keller, B., Bunkòczi, G., Kavanagh, K. L., Lee, W. H., Adamski, J., & Oppermann, U. C. T. (2007) · Biochemical Journal · doi:10.1042/bj20061319 · Cited by 97 · see citing works

Intratumoral Estrogen Disposition in Breast Cancer

Haynes, B. P., Straume, A. H., Geisler, J., A’Hern, R., Helle, H., Smith, I. E., Lønning, P. E., & Dowsett, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2481 · Cited by 96 · see citing works

Pseudo‐symmetry of C19‐steroids, alternative binding orientations and multispecificity in human estrogenic 17β‐hydroxysteroid dehydrogenase

Gangloff, A., Shi, R., Nahoum, V., & Lin, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0397fje · Cited by 96 · see citing works

Molecular Cloning of Mouse 17β‐Hydroxysteroid Dehydrogenase Type 1 and Characterization of Enzyme Activity

Nokelainen, P., Puranen, T., Peltoketo, H., Orava, M., Vihko, P., & Vihko, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00482.x · Cited by 94 · see citing works

Differential expression of 17β‐hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues

Koh, E., Noda, T., Kanaya, J., & Namiki, M. (2002) · The Prostate · doi:10.1002/pros.10139 · Cited by 92 · see citing works

Binding of amyloid β‐peptide to mitochondrial hydroxyacyl‐CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease

Oppermann, U. C. T., Salim, S., Tjernberg, L. O., Terenius, L. Y., & Jörnvall, H. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00586-4 · Cited by 91 · see citing works

Design, Synthesis, and Biological Evaluation of (Hydroxyphenyl)naphthalene and -quinoline Derivatives: Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) for the Treatment of Estrogen-Dependent Diseases

Frotscher, M., Ziegler, E., Marchais‐Oberwinkler, S., Kruchten, P., Neugebauer, A., Fetzer, L., Scherer, C., Müller‐Vieira, U., Messinger, J., Thole, H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701447v · Cited by 89 · see citing works

A concerted, rational design of type 1 17β‐hydroxysteroid dehydrogenase inhibitors: estradiol‐adenosine hybrids with high affinity

Qiu, W., Campbell, R. L., Gangloff, A., Dupuis, P., Boivin, R. P., Tremblay, M. R., Poirier, D., & Lin, S. (2002) · The FASEB Journal · doi:10.1096/fj.02-0026fje · Cited by 85 · see citing works

17β-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein

Horiguchi, Y., Araki, M., & Motojima, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.063 · Cited by 84 · see citing works

Binary and ternary crystal structure analyses of a novel inhibitor with 17β-HSD type 1: a lead compound for breast cancer therapy

Mazumdar, M., Fournier, D., Zhu, D., Cadot, C., Poirier, D., & Lin, S. (2009) · Biochemical Journal · doi:10.1042/bj20091020 · Cited by 84 · see citing works

Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1

Gobec, S., Brožič, P., & Rižner, T. L. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783330629 · Cited by 83 · see citing works

Site-directed mutagenesis of the putative active site of human 17β-hydroxysteroid dehydrogenase type 1

Puranen, T., POUTANEN, M. H., Peltoketo, H., Vihko, P., & Vihko, R. (1994) · Biochemical Journal · doi:10.1042/bj3040289 · Cited by 81 · see citing works

New Insights into the SAR and Binding Modes of Bis(hydroxyphenyl)thiophenes and -benzenes: Influence of Additional Substituents on 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitory Activity and Selectivity

Bey, E., Marchais‐Oberwinkler, S., Negri, M., Kruchten, P., Oster, A., Klein, T., Spadaro, A., Werth, R., Frotscher, M., Birk, B., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901195w · Cited by 77 · see citing works

Steroid dehydrogenase structures, mechanism of action, and disease

Duax, W. L., Ghosh, D., & Pletnev, V. Z. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)58023-6 · Cited by 76 · see citing works

HSD17B10: A gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids

Yang, S., He, X., & Miller, D. L. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.06.001 · Cited by 73 · see citing works

17β-Hydroxysteroid Dehydrogenase 14 Affects Estradiol Levels in Breast Cancer Cells and Is a Prognostic Marker in Estrogen Receptor–Positive Breast Cancer

Jansson, A., Gunnarsson, C., Cohen, M., Sivik, T., & Stål, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1448 · Cited by 73 · see citing works

Characterization of Structural and Functional Properties of Human 17 -Hydroxysteroid Dehydrogenase Type 1 Using Recombinant Enzymes and Site-Directed Mutagenesis

Puranen, T., POUTANEN, M. H., Ghosh, D., Vihko, P., & Vihko, R. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9872 · Cited by 71 · see citing works

Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) for the treatment of estrogen-dependent diseases

Bey, E., Marchais‐Oberwinkler, S., Kruchten, P., Frotscher, M., Werth, R., Oster, A., Algül, Ö., Neugebauer, A., & Hartmann, R. W. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.04.073 · Cited by 65 · see citing works

New selective nonsteroidal aromatase inhibitors: Synthesis and inhibitory activity of 2,3 or 5-(α-azolylbenzyl)-1H-indoles

Borgne, M. L., Marchand, P., Seiller, B., Robert, J.-M., Baut, G. L., Hartmann, R. W., & Palzer, M. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00737-9 · Cited by 65 · see citing works

Substituted 6-Phenyl-2-naphthols. Potent and Selective Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Design, Synthesis, Biological Evaluation, and Pharmacokinetics

Marchais‐Oberwinkler, S., Kruchten, P., Frotscher, M., Ziegler, E., Neugebauer, A., Bhoga, U., Bey, E., Müller‐Vieira, U., Messinger, J., Thole, H., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800367k · Cited by 64 · see citing works

Human Hydroxysteroid (17-β) Dehydrogenase 1 Expression Enhances Estrogen Sensitivity of MCF-7 Breast Cancer Cell Xenografts

Husen, B., Huhtinen, K., Saloniemi, T., Messinger, J., Thole, H., & POUTANEN, M. H. (2006) · Endocrinology · doi:10.1210/en.2006-0778 · Cited by 63 · see citing works

Molecular determinants of steroid recognition and catalysis in aldo-keto reductases. Lessons from 3α-hydroxysteroid dehydrogenase

Penning, T. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00038-2 · Cited by 63 · see citing works

Pan1b (17βHSD11)-enzymatic activity and distribution in the lung

Brereton, P. S., Suzuki, T., Sasano, H., Li, K., Duarte, C., Obeyesekere, V. R., Haeseleer, F., Palczewski, K., Smith, A. I., Komesaroff, P. A., et al. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00417-2 · Cited by 63 · see citing works

Critical Residues for the Specificity of Cofactors and Substrates in Human Estrogenic 17β-Hydroxysteroid Dehydrogenase 1: Variants Designed from the Three-Dimensional Structure of the Enzyme

Huang, Y., Pineau, I., Chang, H.-J., Azzi, A., Bellemare, V., Laberge, S., & Lin, S. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.11.0730 · Cited by 62 · see citing works

Complementary Deoxyribonucleic Acid Cloning and Enzymatic Characterization of a Novel 17 /3 -Hydroxysteroid/Retinoid Short Chain Dehydrogenase/Reductase

Su, J., Lin, M., & Napoli, J. L. (1999) · Endocrinology · doi:10.1210/endo.140.11.7137 · Cited by 58 · see citing works

Synthesis and In Vitro Evaluation of 3‐(1‐Azolylmethyl)‐1H‐indoles and 3‐(1‐Azolyl‐1‐phenylmethyl)‐1H‐indoles as Inhibitors of P450 arom

Borgne, M. L., Marchand, P., Duflos, M., Seiller, B., Robert‐Piessard, S., Baut, G. L., Hartmann, R. W., & Palzer, M. (1997) · Archiv der Pharmazie · doi:10.1002/ardp.19973300506 · Cited by 58 · see citing works

Cloning of rat 17 beta-hydroxysteroid dehydrogenase type 2 and characterization of tissue distribution and catalytic activity of rat type 1 and type 2 enzymes

Akinola, L. A., POUTANEN, M. H., & Vihko, R. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612487 · Cited by 57 · see citing works

Hydroxysteroid (17β) Dehydrogenase 12 Is Essential for Mouse Organogenesis and Embryonic Survival

Rantakari, P., Lagerbohm, H., Kaimainen, M., Suomela, J., Strauss, L., Sainio, K., Pakarinen, P., & POUTANEN, M. H. (2010) · Endocrinology · doi:10.1210/en.2009-0929 · Cited by 57 · see citing works

Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009788680000 · Cited by 57 · see citing works

Dehydroepiandrosterone and Dihydrotestosterone Recognition by Human Estrogenic 17β-Hydroxysteroid Dehydrogenase

Han, Q., Campbell, R. L., Gangloff, A., Huang, Y., & Lin, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1105 · Cited by 56 · see citing works

Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 in vivo in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme

Husen, B., Huhtinen, K., POUTANEN, M. H., Kangas, L., Messinger, J., & Thole, H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.042 · Cited by 56 · see citing works

Amyloid β-Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress

Yan, S. D., Zhu, Y., Stern, E., Hwang, Y. C., Hori, O., Ogawa, S., Frosch, M. P., Connolly, E. S., McTaggart, R., Pinsky, D. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61485-7 · Cited by 56 · see citing works

Recent advances in 17beta-hydroxysteroid dehydrogenases

Prehn, C. P., Möller, G., & Adamski, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.024 · Cited by 55 · see citing works

New inhibitors of 17β-hydroxysteroid dehydrogenase type 1

Messinger, J., Hirvelä, L., Husen, B., Kangas, L., Koskimies, P., Pentikäinen, O. T., Saarenketo, P., & Thole, H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.044 · Cited by 53 · see citing works

HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer

Rasiah, K., Gardiner‐Garden, M., Padilla, E. J. D., Möller, G., Kench, J. G., Alles, M. C., Eggleton, S. A., Stricker, P. D., Adamski, J., Sutherland, R. L., et al. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.021 · Cited by 52 · see citing works

Control of cell proliferation by steroids: The role of 17HSDs

Vihko, P., Herrala, A. M., Härkönen, P. K., ISOMAA, V. V., Kaija, H., Kurkela, R., & Pulkka, A. E. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.005 · Cited by 51 · see citing works

Amyloid beta -peptide-binding alcohol dehydrogenase is a component of the cellular response to nutritional stress.

Yan, S. D., Zhu, Y., Stern, E. D., Hwang, Y. C., Hori, O., Ogawa, S., Frosch, M. P., Connolly, E. S., McTaggart, R., Pinsky, D. J., et al. (2000) · PubMed · doi:10.1074/jbc.m000055200 · Cited by 51 · see citing works

Inhibitors of type II 17β-hydroxysteroid dehydrogenase

Poirier, D., Bydal, P., Tremblay, M. R., Sam, K., & Luu-The, V. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00427-5 · Cited by 50 · see citing works

17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer

Jansson, A. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.12.012 · Cited by 50 · see citing works

Enzymes as modulators in malignant transformation

Vihko, P., Herrala, A. M., Härkönen, P. K., ISOMAA, V. V., Kaija, H., Kurkela, R., Li, Y., Patrikainen, L., Pulkka, A. E., Soronen, P., et al. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.01.002 · Cited by 49 · see citing works

5-Phenyl substituted 1-methyl-2-pyridones and 4′-substituted biphenyl-4-carboxylic acids. synthesis and evaluation as inhibitors of steroid-5α-reductase type 1 and 2

Picard, F., Schulz, T., & Hartmann, R. W. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00293-0 · Cited by 47 · see citing works

Hydroxysteroid (17β) Dehydrogenase 7 Activity Is Essential for Fetal de Novo Cholesterol Synthesis and for Neuroectodermal Survival and Cardiovascular Differentiation in Early Mouse Embryos

Jokela, H., Rantakari, P., Lamminen, T., Strauss, L., Ola, R., Mutka, A., Gylling, H. K., Miettinen, T. A., Pakarinen, P., Sainio, K., et al. (2010) · Endocrinology · doi:10.1210/en.2009-0928 · Cited by 47 · see citing works

Sequence of mouse 17β-hydroxysteroid dehydrogenase type 3 cDNA and tissue distribution of the type 1 and type 3 isoform mRNAs

Sha, J. A., Dudley, K., Rajapaksha, W. R. A. K. J. S., & O’Shaughnessy, P. J. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00165-3 · Cited by 46 · see citing works

Structure-based design, synthesis and in vitro characterization of potent 17β-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone

Möller, G., Deluca, D., Gege, C., Rosinus, A., Kowalik, D., Peters, O., Droescher, P., Elger, W. A. G., Adamski, J., & Hillisch, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.113 · Cited by 45 · see citing works

Amino acid substitution of arginine 80 in 17β-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics

McKeever, B. M., Hawkins, B. K., Geissler, W. M., Wu, L., Sheridan, R. P., Mosley, R. T., & Andersson, S. (2002) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(02)00434-x · Cited by 44 · see citing works

Coumarins as novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors for potential treatment of prostate cancer

Harada, K., Kubo, H., Tomigahara, Y., Nishioka, K., Takahashi, J., Momose, M., Inoue, S., & Kojima, A. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.111 · Cited by 44 · see citing works

Mechanistic Roles of Ser-114, Tyr-155, and Lys-159 in 3α-Hydroxysteroid Dehydrogenase/Carbonyl Reductase from Comamonas testosteroni

Hwang, C., Chang, Y., Hsu, C., Hsu, H.-H., Li, C., & Pon, H.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411751200 · Cited by 41 · see citing works

Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1: Templates for design

Allan, G. M., Vicker, N., Lawrence, H. R., Tutill, H. J., Day, J. M., Huchet, M., Ferrandis, E., Reed, M. J., Purohit, A., & Potter, B. V. L. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.02.059 · Cited by 40 · see citing works

Selective inhibition of 17β-hydroxysteroid dehydrogenase type 1 (17βHSD1) reduces estrogen responsive cell growth of T47-D breast cancer cells

Kruchten, P., Werth, R., Bey, E., Oster, A., Marchais‐Oberwinkler, S., Frotscher, M., & Hartmann, R. W. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.02.006 · Cited by 40 · see citing works

Novel Hydroxysteroid (17β) Dehydrogenase 1 Inhibitors Reverse Estrogen-Induced Endometrial Hyperplasia in Transgenic Mice

Saloniemi, T., Järvensivu, P., Koskimies, P., Jokela, H., Lamminen, T., Ghaem‐Maghami, S., Dina, R. E., Damdimopoulou, P., Mäkelä, S., Perheentupa, A. H., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090325 · Cited by 40 · see citing works

Perspectives in Understanding the Role of Human 17β‐Hydroxysteroid Dehydrogenases in Health and Disease

Meier, M., Möller, G., & Adamski, J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03702.x · Cited by 40 · see citing works

Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5α-reductase type 1 and 2

Picard, F., Baston, E., Reichert, W., & Hartmann, R. W. (2000) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00070-5 · Cited by 39 · see citing works

Synthesis and Biological Evaluation of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1) Inhibitors Based on a Thieno[2,3-d]pyrimidin-4(3H)-one Core

Lilienkampf, A., Karkola, S., Alho-Richmond, S., Koskimies, P., Johansson, N., Huhtinen, K., Vihko, K. K., & Wähälä, K. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900928k · Cited by 39 · see citing works

Induction of endometriosis in the marmoset monkey (Callithrix jacchus)

Einspanier, A. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal031 · Cited by 39 · see citing works

N-substituted 4-(5-indolyl)benzoic acids. Synthesis and evaluation of steroid 5α-reductase type I and II inhibitory activity

Baston, E., & Hartmann, R. W. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00234-6 · Cited by 37 · see citing works

Molecular mechanisms of estrogen recognition and 17-keto reduction by human 17β-hydroxysteroid dehydrogenase 1

Ghosh, D., & Vihko, P. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00255-6 · Cited by 37 · see citing works

Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities

Bydal, P., Luu-The, V., Labrie, F., & Poirier, D. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.03.020 · Cited by 36 · see citing works

A 3D QSAR Model of 17β‐HSD1 Inhibitors Based on a Thieno[2,3‐d]pyrimidin‐4(3H)‐one Core Applying Molecular Dynamics Simulations and Ligand–Protein Docking

Karkola, S., Lilienkampf, A., & Wähälä, K. (2008) · ChemMedChem · doi:10.1002/cmdc.200700271 · Cited by 35 · see citing works

Estrone C15 derivatives—A new class of 17β-hydroxysteroid dehydrogenase type 1 inhibitors

Messinger, J., Husen, B., Koskimies, P., Hirvelä, L., Kallio, L., Saarenketo, P., & Thole, H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.022 · Cited by 35 · see citing works

Androgenic and estrogenic 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms

Blomquist, C. H., Bonenfant, M., McGinley, D. M., Pósalaky, Z., LAKATUA, D. J., Tuli-Puri, S., Bealka, D. G., & Tremblay, Y. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00117-6 · Cited by 34 · see citing works

Increased Expression of Type I 17β-Hydroxysteroid Dehydrogenase Enhancesin SituProduction of Estradiol in Uterine Leiomyoma

Kasai, T., Shozu, M., Murakami, K., Segawa, T., Shinohara, K., Nomura, K., & Inoue, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032085 · Cited by 34 · see citing works

Cofactors, redox state, and directional preferences of hydroxysteroid dehydrogenases

Sherbet, D. P., Papari-Zareei, M., Khan, N., Sharma, K. K., Brandmaier, A., Rambally, S., Chattopadhyay, A., Andersson, S., Agarwal, A. K., & Auchus, R. J. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.021 · Cited by 33 · see citing works

Novel estrone mimetics with high 17β-HSD1 inhibitory activity

Oster, A., Klein, T., Werth, R., Kruchten, P., Bey, E., Negri, M., Marchais‐Oberwinkler, S., Frotscher, M., & Hartmann, R. W. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.065 · Cited by 32 · see citing works

Placenta Defects and Embryonic Lethality Resulting from Disruption of Mouse Hydroxysteroid (17-β) Dehydrogenase 2 Gene

Rantakari, P., Strauss, L., Kiviranta, R., Lagerbohm, H., Paviala, J., Holopainen, I. E., Vainio, S. J., Pakarinen, P., & POUTANEN, M. H. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0257 · Cited by 32 · see citing works

Potent and Selective Steroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 7, an Enzyme That Catalyzes the Reduction of the Key Hormones Estrone and Dihydrotestosterone

Bellavance, É., Luu-The, V., & Poirier, D. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900921c · Cited by 31 · see citing works

Ke 6 Gene

Maxwell, M. M., Nearing, J., & Aziz, N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25213 · Cited by 31 · see citing works

The design of novel 17β-hydroxysteroid dehydrogenase type 3 inhibitors

Vicker, N., Sharland, C. M., Heaton, W. B., Ramos, A., Bailey, H. V., Smith, A. C., Springall, J. S., Day, J. M., Tutill, H. J., Reed, M. J., et al. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.005 · Cited by 30 · see citing works

Structure–activity study in the class of 6-(3′-hydroxyphenyl)naphthalenes leading to an optimization of a pharmacophore model for 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitors

Marchais‐Oberwinkler, S., Frotscher, M., Ziegler, E., Werth, R., Kruchten, P., Messinger, J., Thole, H., & Hartmann, R. W. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.024 · Cited by 29 · see citing works

Effect of 17beta-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys.

Cm, B., Wood, J. E., Wilkie, D., & DIXON, B. K. (2008) · PubMed · Cited by 29 · see citing works

Insights in 17β-HSD1 Enzyme Kinetics and Ligand Binding by Dynamic Motion Investigation

Negri, M., Recanatini, M., & Hartmann, R. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012026 · Cited by 28 · see citing works

The role of the heterocycle in bis(hydroxyphenyl)triazoles for inhibition of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) type 1 and type 2

Al‐Soud, Y. A., Bey, E., Oster, A., Marchais‐Oberwinkler, S., Werth, R., Kruchten, P., Frotscher, M., & Hartmann, R. W. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.012 · Cited by 27 · see citing works

Transgenic Male Mice Expressing Human Hydroxysteroid Dehydrogenase 2 Indicate a Role for the Enzyme Independent of Its Action on Sex Steroids

Zhongyi, S., Rantakari, P., Lamminen, T., Toppari, J., & POUTANEN, M. H. (2007) · Endocrinology · doi:10.1210/en.2007-0365 · Cited by 23 · see citing works

Species Used for Drug Testing Reveal Different Inhibition Susceptibility for 17beta-Hydroxysteroid Dehydrogenase Type 1

Möller, G., Husen, B., Kowalik, D., Hirvelä, L., Plewczyński, D., Rychlewski, L., Messinger, J., Thole, H., & Adamski, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010969 · Cited by 23 · see citing works

Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17β-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells

Sherbet, D. P., Guryev, O. L., Papari-Zareei, M., Mizrachi, D., Rambally, S., Akbar, S., & Auchus, R. J. (2009) · Endocrinology · doi:10.1210/en.2008-1817 · Cited by 22 · see citing works

5α-Reductase in Intact DU145 Cells: Evidence for Isozyme I and Evaluation of Novel Inhibitors

Reichert, W., Jose, J., & Hartmann, R. W. (2000) · Archiv der Pharmazie · doi:10.1002/1521-4184(20007)333:7 · Cited by 17 · see citing works

Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17β-hydroxysteroid dehydrogenase Type 3

Day, J. M., Tutill, H. J., Foster, P., Bailey, H. V., Heaton, W. B., Sharland, C. M., Vicker, N., Potter, B. V. L., Purohit, A., & Reed, M. J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.014 · Cited by 16 · see citing works

Molecular Framework of Steroid/Retinoid Discrimination in 17β-Hydroxysteroid Dehydrogenase Type 1 and Photoreceptor-associated Retinol Dehydrogenase

Haller, F., Momán, E., Hartmann, R. W., Adamski, J., & Mindnich, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.002 · Cited by 15 · see citing works

Overexpression of Human Hydroxysteroid (17β) Dehydrogenase 2 Induces Disturbance in Skeletal Development in Young Male Mice

Shen, Z., Peng, Z., Sun, Y., Väänänen, H. K., & POUTANEN, M. H. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080322 · Cited by 15 · see citing works

Non-genomic signaling by steroids

Prossnitz, E. R., & Maggiolini, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.04.005 · Cited by 14 · see citing works

Active site analysis of 17β-hydroxysteroid dehydrogenase type 1 enzyme complexes with SPROUT

Alho-Richmond, S., Lilienkampf, A., & Wähälä, K. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.004 · Cited by 14 · see citing works

Design, chemical synthesis, and in vitro biological evaluation of simplified estradiol–adenosine hybrids as inhibitors of 17β-hydroxysteroid dehydrogenase type 1

Bérubé, M., & Poirier, D. (2009) · Canadian Journal of Chemistry · doi:10.1139/v09-083 · Cited by 13 · see citing works

In vivo mouse model for analysis of hydroxysteroid (17β) dehydrogenase 1 inhibitors

Lamminen, T., Saloniemi, T., Huhtinen, K., Koskimies, P., Messinger, J., Husen, B., Thole, H., & POUTANEN, M. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.034 · Cited by 12 · see citing works

Ligand-based NMR spectra demonstrate an additional phytoestrogen binding site for 17β-hydroxysteroid dehydrogenase type 1

Michiels, P. J. A., Ludwig, C., Stephan, M., Fischer, C., Möller, G., Messinger, J., van Dongen, M. J. P., Thole, H., Adamski, J., & Günther, U. L. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.07.004 · Cited by 11 · see citing works

Development of biological assays for the identification of selective inhibitors of estradiol formation from estrone in rat liver preparations

Kruchten, P., Werth, R., Marchais‐Oberwinkler, S., Bey, E., Ziegler, E., Oster, A., Frotscher, M., & Hartmann, R. W. (2009) · Comptes Rendus Chimie · doi:10.1016/j.crci.2009.05.005 · Cited by 10 · see citing works

ChemInform Abstract: Synthesis and in vitro Evaluation of 3‐(1‐Azolylmethyl)‐1H‐indoles and 3‐(1‐Azolyl‐1‐phenylmethyl)‐1H‐indoles as Inhibitors of P450 Arom.

Borgne, M. L., Marchand, P., Duflos, M., SEILLER, B., Robert‐Piessard, S., Baut, G. L., Hartmann, R. W., & Palzer, M. (1997) · ChemInform · doi:10.1002/chin.199742155 · Cited by 10 · see citing works

Search for Potential Non-Steroidal Inhibitors of 17 β-Hydroxysteroid Dehydrogenase (17 β-HSD) in the Treatment of Hormone-Dependent Cancers

Lota, R. K., Dhanani, S., Owen, C. P., & Ahmed, S. (2007) · Letters in Drug Design & Discovery · doi:10.2174/157018007780077417 · Cited by 10 · see citing works

6-Substituted 3,4-Dihydro-naphthalene-2-carboxylic Acids: Synthesis and Structure-Activity Studies in a Novel Class of Human 5α Reductase Inhibitors

Baston, E., Salem, O. I. A., & Hartmann, R. W. (2002) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/1475636021000059092 · Cited by 9 · see citing works

Preparation of 16β-Estradiol Derivative Libraries as Bisubstrate Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 Using the Multidetachable Sulfamate Linker

Bérubé, M., Delagoutte, F., & Poirier, D. (2010) · Molecules · doi:10.3390/molecules15031590 · Cited by 9 · see citing works

Chemical Synthesis, 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitory Activity and Assessment of In Vitro and In Vivo Estrogenic Activities of Estradiol Derivatives

Rouillard, F., Lefebvre, J., Fournier, M.-A., & Poirier, D. (2008) · The Open Enzyme Inhibition Journal · doi:10.2174/1874940200801010061 · Cited by 7 · see citing works

Effect of Free and in Poly(η-caprolactone) Nanoparticles Incorporated New Type 1 17β -Hydroxysteroid Dehydrogenase Inhibitors on Cancer Cells

Kocbek, P., Teskač, K., Brožič, P., Rižner, T. L., Gobec, S., & Kristl, J. (2010) · Current Nanoscience · doi:10.2174/157341310790226397 · Cited by 3 · see citing works

Inhibition of 17β -Hydroxysteroid Dehydrogenase (17β -HSD) by Imidazole-Based Compounds

Ahmed, S., Olusanjo, M. S., Shahid, I., & Owen, C. (2008) · Letters in Drug Design & Discovery · doi:10.2174/157018008783406705 · Cited by 2 · see citing works

Hormonal Therapy for Prostate Cancer

Desai, K. B., McManus, J. M., & Sharifi, N. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab002 · Cited by 461 · see citing works

Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review

Schiffer, L., Barnard, L., Baranowski, E. S., Gilligan, L. C., Taylor, A. E., Arlt, W., Shackleton, C. H. L., & Storbeck, K.-H. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105439 · Cited by 450 · see citing works

17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease

Ma, Y., Belyaeva, O. V., Brown, P. M., Fujita, K., Valles, K., Karki, S., de Boer, Y. S., Koh, C., Chen, Y., Du, X., et al. (2018) · Hepatology · doi:10.1002/hep.30350 · Cited by 310 · see citing works

The Role of Sex and Sex Hormones in Neurodegenerative Diseases

Vegeto, E., Villa, A. M., Torre, S. D., Crippa, V., Rusmini, P., Cristofani, R., Galbiati, M., Maggi, A. C., & Poletti, A. (2019) · Endocrine Reviews · doi:10.1210/endrev/bnz005 · Cited by 231 · see citing works

Comparative proteomic study reveals 17β-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease

Su, W., Wang, Y., Jia, X., Wu, W., Li, L., Tian, X., Li, S., Wang, C., Xu, H.-M., Cao, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410741111 · Cited by 222 · see citing works

Current status on development of steroids as anticancer agents

Gupta, A. K., Kumar, B. S., & Negi, A. S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.05.011 · Cited by 218 · see citing works

Intracrine androgen biosynthesis, metabolism and action revisited

Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217 · see citing works

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases

Kaserer, T., Beck, K. R., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 208 · see citing works

Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels

Huhtinen, K., Desai, R., Ståhle, M., Salminen, A., Handelsman, D. J., Perheentupa, A., & Poutanen, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1154 · Cited by 195 · see citing works

The structural biology of oestrogen metabolism

THOMAS, M. P., & Potter, B. V. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.12.014 · Cited by 181 · see citing works

Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights

Byrns, M. C., Jin, Y., & Penning, T. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.11.004 · Cited by 144 · see citing works

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease

Pirola, C. J., Garaycoechea, M. E., Flichman, D. M., Arrese, M. A., Martino, J. S., Gazzi, C., Castaño, G. O., & Sookoian, S. C. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p089953 · Cited by 141 · see citing works

Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women

Hetemäki, N., Savolainen-Peltonen, H., Tikkanen, M. J., Wang, F., Paatela, H., Hämäläinen, E., Turpeinen, U., Haanpää, M., Vihma, V., & Mikkola, T. S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01474 · Cited by 140 · see citing works

AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders

Penning, T. M. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.07.002 · Cited by 117 · see citing works

Estrogen biosynthesis and signaling in endometriosis

Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107 · see citing works

Overexpression of Aromatase Alone is Sufficient for Ovarian Development in Genetically Male Chicken Embryos

Lambeth, L. S., Cummins, D. M., Doran, T. J., Sinclair, A. H., & Smith, C. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068362 · Cited by 82 · see citing works

Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders

Yang, S., He, X., Isaacs, C. E., Dobkin, C., Miller, D. L., & Philipp, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.001 · Cited by 82 · see citing works

Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)

He, W., Misra, G., Li, T., Wang, R., & Lin, S. (2016) · Gene · doi:10.1016/j.gene.2016.04.031 · Cited by 78 · see citing works

Multigenerational and Transgenerational Effects of Environmentally Relevant Concentrations of Endocrine Disruptors in an Estuarine Fish Model

DeCourten, B. M., Forbes, J. P., Roark, H. K., Burns, N. P., Major, K. M., White, J. W., Li, J., Mehinto, A. C., Connon, R. E., & Brander, S. M. (2020) · Environmental Science & Technology · doi:10.1021/acs.est.0c02892 · Cited by 72 · see citing works

The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors

Secky, L., Svoboda, M., Klameth, L., Bajna, E., Hamilton, G., Zeillinger, R., Jäger, W. R., & Thalhammer, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/957605 · Cited by 71 · see citing works

Role of HSD17B13 in the liver physiology and pathophysiology

Su, W., Mao, Z., Liu, Y., Zhang, X., Zhang, W., Gustafsson, J.-Α., & Guan, Y. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.014 · Cited by 67 · see citing works

Activity of Zearalenone in the Porcine Intestinal Tract

Gajęcka, M., Zielonka, Ł., & Gajęcki, M. T. (2016) · Molecules · doi:10.3390/molecules22010018 · Cited by 66 · see citing works

17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury

Ma, Y., Brown, P. M., Lin, D. D., Ma, J., Feng, D., Belyaeva, O. V., Podszun, M. C., Roszik, J., Allen, J. N., Umarova, R., et al. (2020) · Hepatology · doi:10.1002/hep.31517 · Cited by 64 · see citing works

Characteristics and sex dimorphism of 17β-hydroxysteroid dehydrogenase family genes in the olive flounder Paralichthys olivaceus

Zou, C., Wang, L., Zou, Y., Wu, Z., Wang, W., Liang, S., Wang, L., & You, F. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105597 · Cited by 61 · see citing works

In silico methods in the discovery of endocrine disrupting chemicals

Vuorinen, A., Odermatt, A., & Schuster, D. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.009 · Cited by 58 · see citing works

Engineering Mycobacterium smegmatis for testosterone production

Fernández‐Cabezón, L., Galán, B., & García, J. L. (2016) · Microbial Biotechnology · doi:10.1111/1751-7915.12433 · Cited by 58 · see citing works

Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity

Ayan, D. P., Roy, J., Maltais, R., & Poirier, D. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.07.009 · Cited by 57 · see citing works

The Adrenal Cortex and its Disorders

Miller, W. L. (2009) · Wiley eBooks · doi:10.1002/9781444316728.ch13 · Cited by 51 · see citing works

Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluation

Penning, T. M. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.01.009 · Cited by 50 · see citing works

Optimization of Hydroxybenzothiazoles as Novel Potent and Selective Inhibitors of 17β-HSD1

Spadaro, A., Frotscher, M., & Hartmann, R. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201711b · Cited by 50 · see citing works

Discovery of a novel enzyme mediating glucocorticoid catabolism in fish: 20beta-hydroxysteroid dehydrogenase type 2

Tokarz, J., Mindnich, R., Norton, W., Möller, G., Hrabé de Angelis, M., & Adamski, J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.022 · Cited by 48 · see citing works

Emerging hallmarks of endometriosis metabolism: A promising target for the treatment of endometriosis

Lu, J., Ling, X., Liu, L., Jiang, A., Ren, C., Lü, C., & Yu, Z. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119381 · Cited by 48 · see citing works

Functional Silencing of HSD17B2 in Prostate Cancer Promotes Disease Progression

Gao, X., Dai, C. S., Huang, S., Tang, J., Chen, G., Li, J., Zhu, Z., Zhu, X., Zhou, S., Gao, Y., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2392 · Cited by 48 · see citing works

17β-Estradiol and Estradiol Fatty Acyl Esters and Estrogen-Converting Enzyme Expression in Adipose Tissue in Obese Men and Women

Wang, F., Vihma, V., Soronen, J., Turpeinen, U., Hämäläinen, E. K., Savolainen-Peltonen, H. M., Mikkola, T. S., Naukkarinen, J., Pietiläinen, K. H., Jauhiainen, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2605 · Cited by 48 · see citing works

Introduction of an Electron Withdrawing Group on the Hydroxyphenylnaphthol Scaffold Improves the Potency of 17β-Hydroxysteroid Dehydrogenase Type 2 (17β-HSD2) Inhibitors

Wetzel, M., Marchais‐Oberwinkler, S., Perspicace, E., Möller, G., Adamski, J., & Hartmann, R. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2008453 · Cited by 47 · see citing works

Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease

Vinklářová, L., Schmidt, M., Benek, O., Kuča, K., Gunn‐Moore, F. J., & Musílek, K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15027 · Cited by 42 · see citing works

Breast Adipose Tissue Estrogen Metabolism in Postmenopausal Women With or Without Breast Cancer

Savolainen-Peltonen, H. M., Vihma, V., Leidenius, M., Wang, F., Turpeinen, U., Hämäläinen, E. K., Tikkanen, M. J., & Mikkola, T. S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2550 · Cited by 41 · see citing works

Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats

Yin, J., Lu, J., Peng, L., He, M., Huang, S., Lv, J., Zhu, Y., Liu, Z., & Jiang, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671708 · Cited by 39 · see citing works

Direct and indirect parental exposure to endocrine disruptors and elevated temperature influences gene expression across generations in a euryhaline model fish

DeCourten, B. M., Connon, R. E., & Brander, S. M. (2019) · PeerJ · doi:10.7717/peerj.6156 · Cited by 39 · see citing works

Virtual screening applications in short-chain dehydrogenase/reductase research

Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 38 · see citing works

Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges

Salah, M., Abdelsamie, A. S., & Frotscher, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.10.001 · Cited by 38 · see citing works

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)

Spadaro, A., Negri, M., Marchais‐Oberwinkler, S., Bey, E., & Frotscher, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029252 · Cited by 36 · see citing works

Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease

Zhang, X., Wang, Y., & Liu, P. (2016) · Protein & Cell · doi:10.1007/s13238-016-0327-9 · Cited by 36 · see citing works

Enzymatic preparation of Crassostrea oyster peptides and their promoting effect on male hormone production

Zhang, W., Wei, Y., Cao, X., Guo, K., Wang, Q., Xiao, X., Zhai, X., Wang, D., & Huang, Z. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113382 · Cited by 35 · see citing works

Hydroxysteroid (17β) dehydrogenase 12 is essential for metabolic homeostasis in adult mice

Heikelä, H., Ruohonen, S. T., Adam, M., Viitanen, R., Liljenbäck, H., Eskola, O., Gabriel, M., Mairinoja, L., Pessia, A., Velagapudi, V., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00042.2020 · Cited by 34 · see citing works

Synthesis and structure–activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis

Bacsa, I., Herman, B. E., Jójárt, R., Herman, K. S., Woelfling, J., Schneider, G., Varga, M., Tömböly, C., Rižner, T. L., Szécsi, M., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1490731 · Cited by 33 · see citing works

Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-( m -carbamoylbenzyl)-estradiol Derivatives

Maltais, R., Ayan, D. P., Trottier, A., Barbeau, X., Lagüe, P., Bouchard, J., & Poirier, D. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401639v · Cited by 33 · see citing works

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma

Zhu, P., Feng, R., Lu, X., Liao, Y., Du, Z., Zhai, W., & Chen, K. (2021) · Aging · doi:10.18632/aging.202380 · Cited by 32 · see citing works

The Effect of Low Monotonic Doses of Zearalenone on Selected Reproductive Tissues in Pre-Pubertal Female Dogs—A Review

Gajęcka, M., Zielonka, Ł., & Gajęcki, M. T. (2015) · Molecules · doi:10.3390/molecules201119726 · Cited by 32 · see citing works

Growth performance, selected blood biochemical parameters and body weights of pre-pubertal gilts fed diets supplemented with different doses of zearalenone (ZEN)

Rykaczewska, A., Gajęcka, M., Dąbrowski, M., Wiśniewska, A., Szcześniewska, J., Gajęcki, M. T., & Zielonka, Ł. (2018) · Toxicon · doi:10.1016/j.toxicon.2018.07.013 · Cited by 30 · see citing works

Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity

Ma, Y., Karki, S., Brown, P. M., Lin, D. D., Podszun, M. C., Zhou, W., Belyaeva, O. V., Kedishvili, N. Y., & Rotman, Y. (2020) · Journal of Lipid Research · doi:10.1194/jlr.ra120000907 · Cited by 30 · see citing works

Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13

(2023) · doi:10.1038/s41467-023-40766-0 · Cited by 29 · see citing works

Characteristics of 17β-hydroxysteroid dehydrogenase 8 and its potential role in gonad of Zhikong scallop Chlamys farreri

Liu, J., Zhang, Z., Ma, X., Liang, S., & Yang, D. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.01.008 · Cited by 29 · see citing works

Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients

Benedittis, C. D., Bellan, M., Crevola, M., Boin, E., Barbaglia, M. N., Mallela, V. R., Ravanini, P., Ceriani, E., Fangazio, S., Sainaghi, P. P., et al. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/4216451 · Cited by 29 · see citing works

Molecular cloning and expression analysis of 17β-hydroxysteroid dehydrogenase 1 and 12 during gonadal development, recrudescence and after in vivo hCG induction in catfish, Clarias batrachus

Anbazhagan, R., & Senthilkumaran, B. (2014) · Steroids · doi:10.1016/j.steroids.2014.09.009 · Cited by 29 · see citing works

Human DHRS7, promising enzyme in metabolism of steroids and retinoids?

Navrátilová, H., Zemanová, L., Lundová, T., Malčeková, B., Skarka, A., Šafr, M., & Wsól, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.09.041 · Cited by 28 · see citing works

Gonad transcriptome analysis reveals the differences in gene expression related to sex-biased and reproduction of clam Cyclina sinensis

Liu, M., Ni, H., Rong, Z., Wang, Z., Yan, S., Liao, X., & Dong, Z. (2023) · Frontiers in Marine Science · doi:10.3389/fmars.2022.1110587 · Cited by 27 · see citing works

Disrupting KATP channels diminishes the estrogen-mediated protection in female mutant mice during ischemia-reperfusion

Gao, J., Xu, D. H., Sabat, G., Valdivia, H. H., Xu, W. G., & Shi, N. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-19 · Cited by 27 · see citing works

Structural basis for inhibition of 17β-hydroxysteroid dehydrogenases by phytoestrogens: The case of fungal 17β-HSDcl

Cassetta, A., Stojan, J., Krastanova, I. B., Kristan, K., Brunskole, M., Lamba, D., & Rižner, T. L. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.02.020 · Cited by 27 · see citing works

Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosis

Wetzel, M., Gargano, E. M., Hinsberger, S., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.09.004 · Cited by 25 · see citing works

Male-Dominant Activation of Rat Renal Organic Anion Transporter 1 (Oat1) and 3 (Oat3) Expression by Transcription Factor BCL6

Wegner, W., Burckhardt, B. C., Burckhardt, G., & Henjakovic, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035556 · Cited by 25 · see citing works

Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide

Li, T., Maltais, R., Poirier, D., & Lin, S. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b02225 · Cited by 25 · see citing works

Discovery of a Novel Potent and Selective HSD17B13 Inhibitor, BI-3231, a Well-Characterized Chemical Probe Available for Open Science

Thamm, S., Willwacher, M. K., Aspnes, G. E., Bretschneider, T., Brown, N. F., Buschbom-Helmke, S., Fox, T., Gargano, E. M., Grabowski, D., Hoenke, C., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01884 · Cited by 24 · see citing works

Towards precision medicine in non-alcoholic fatty liver disease

Francque, S. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09820-6 · Cited by 24 · see citing works

Cohort Profile: the Predictors of Breast Cancer Recurrence (ProBe CaRE) Premenopausal Breast Cancer Cohort Study in Denmark

Collin, L. J., Cronin-Fenton, D. P., Ahern, T. P., Christiansen, P., Damkier, P., Ejlertsen, B., Hamilton-Dutoit, S. J., Kjærsgaard, A., Silliman, R. A., Sørensen, H. T., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021805 · Cited by 23 · see citing works

17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease

Wang, M., & Peng, Z. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108428 · Cited by 23 · see citing works

Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol

Maltais, R., Ayan, D. P., & Poirier, D. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200093v · Cited by 23 · see citing works

The effect of experimental low zearalenone intoxication on ovarian follicles in pre-pubertal bitches

Gajęcka, M. (2013) · Polish Journal of Veterinary Sciences · doi:10.2478/pjvs-2013-0007 · Cited by 23 · see citing works

First Structure–Activity Relationship of 17β-Hydroxysteroid Dehydrogenase Type 14 Nonsteroidal Inhibitors and Crystal Structures in Complex with the Enzyme

Braun, F., Bertoletti, N., Möller, G., Adamski, J., Steinmetzer, T., Salah, M., Abdelsamie, A. S., van Koppen, C. J., Heine, A., Klebe, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01436 · Cited by 22 · see citing works

Determination of the topology of endoplasmic reticulum membrane proteins using redox-sensitive green-fluorescence protein fusions

Tsachaki, M., Birk, J., Egert, A., & Odermatt, A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.002 · Cited by 22 · see citing works

Synthesis and Biological Evaluation of Triazolyl 13α-Estrone–Nucleoside Bioconjugates

Bodnár, B., Mernyák, E., Woelfling, J., Schneider, G., Herman, B. E., Szécsi, M., Sinka, I., Zupkó, I., Kupihár, Z., & Kovács, L. (2016) · Molecules · doi:10.3390/molecules21091212 · Cited by 22 · see citing works

Synthesis of novel 13α-estrone derivatives by Sonogashira coupling as potential 17β-HSD1 inhibitors

Bacsa, I., Jójárt, R., Woelfling, J., Schneider, G., Herman, B. E., Szécsi, M., & Mernyák, E. (2017) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.13.126 · Cited by 22 · see citing works

Intracrinology-revisited and prostate cancer

Penning, T. M., & Detlefsen, A. J. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105499 · Cited by 22 · see citing works

Molecular Mechanism Study on Stereo-Selectivity of α or β Hydroxysteroid Dehydrogenases

Gao, M., Nie, K., Qin, M., Xu, H.-J., Wang, F., & Liu, L. (2021) · Crystals · doi:10.3390/cryst11030224 · Cited by 22 · see citing works

The Genus Eriosema (Fabaceae): From the Ethnopharmacology to an Evidence-Based Phytotherapeutic Perspective?

Ateba, S. B., Njamen, D., & Krenn, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.641225 · Cited by 20 · see citing works

Psoralen prevents the inactivation of estradiol and treats osteoporosis via covalently targeting HSD17B2

Lu, Y., Zhang, M., Zhang, J., Jiang, M., & Bai, G. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116426 · Cited by 20 · see citing works

Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10

Boutin, S., Roy, J., Maltais, R., Alata, W., Calon, F., & Poirier, D. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.09.031 · Cited by 20 · see citing works

Rational design of 17β-hydroxysteroid dehydrogenase type3 for improving testosterone production with an engineered Pichia pastoris

Ding, J., You, S., Zhang, J., Zhang, H., Wang, H., Zhang, W., Qi, W. D., Su, R., & He, Z. (2021) · Bioresource Technology · doi:10.1016/j.biortech.2021.125833 · Cited by 20 · see citing works

Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women

Paatela, H., Wang, F., Vihma, V., Savolainen-Peltonen, H., Mikkola, T. S., Turpeinen, U., Hämäläinen, E., Jauhiainen, M., & Tikkanen, M. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-0831 · Cited by 19 · see citing works

Pd-Catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors

Jójárt, R., Pécsy, S., Keglevich, G., Szécsi, M., Laczkó-Rigó, R., Özvegy‐Laczka, C., Kecskeméti, G., & Mernyák, E. (2018) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.14.262 · Cited by 19 · see citing works

Synthesis of 17β-hydroxysteroid dehydrogenase type 10 steroidal inhibitors: Selectivity, metabolic stability and enhanced potency

Boutin, S., Maltais, R., Roy, J., & Poirier, D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112909 · Cited by 19 · see citing works

A Targeted-Covalent Inhibitor of 17β-HSD1 Blocks Two Estrogen-Biosynthesis Pathways: In Vitro (Metabolism) and In Vivo (Xenograft) Studies in T-47D Breast Cancer Models

Poirier, D., Roy, J., & Maltais, R. (2021) · Cancers · doi:10.3390/cancers13081841 · Cited by 19 · see citing works

Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities

Perspicace, E., Cozzoli, L., Gargano, E. M., Hanke, N., Carotti, A., Hartmann, R. W., & Marchais‐Oberwinkler, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.036 · Cited by 19 · see citing works

Neurosteroids: A potential target for neuropsychiatric disorders

Wang, M., Hu, S.-W., Fu, X., Zhou, H., Yang, S., & Yang, C. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106485 · Cited by 18 · see citing works

Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3

Djigoué, G. B., Kenmogne, L. C., Roy, J., Maltais, R., & Poirier, D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.049 · Cited by 18 · see citing works

Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors

Gargano, E. M., Perspicace, E., Hanke, N., Carotti, A., Marchais‐Oberwinkler, S., & Hartmann, R. W. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.061 · Cited by 18 · see citing works

Treatment of estrogen-dependent diseases: Design, synthesis and profiling of a selective 17β-HSD1 inhibitor with sub-nanomolar IC 50 for a proof-of-principle study

Abdelsamie, A. S., van Koppen, C. J., Bey, E., Salah, M., Börger, C., Siebenbürger, L., Laschke, M. W., Menger, M. D., & Frotscher, M. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.11.004 · Cited by 18 · see citing works

Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments

Maltais, R., Trottier, A., Roy, J., Ayan, D. P., Bertrand, N., & Poirier, D. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.12.007 · Cited by 18 · see citing works

Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction

Strauss, J. F., & FitzGerald, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00004-4 · Cited by 18 · see citing works

The effect of environmental mycotoxins on selected ovarian tissue fragments of multiparous female wild boars at the beginning of astronomical winter

Zielonka, Ł., Gajęcka, M., Rozicka, A., Dąbrowski, M., Żmudzki, J., & Gajęcki, M. T. (2014) · Toxicon · doi:10.1016/j.toxicon.2014.06.021 · Cited by 18 · see citing works

Exploring the anti-breast cancer potential of flavonoid analogs

Thakor, V., Poddar, M., Dey, S. K., Manjula, S. N., Madhunapantula, S. V., Pawara, R. H., Patel, H., & Noolvi, M. N. (2016) · RSC Advances · doi:10.1039/c6ra14428d · Cited by 18 · see citing works

17β-HSD type 12-like is responsible for maturation-inducing hormone synthesis during oocyte maturation in masu salmon12

Ijiri, S., Shibata, Y., Takezawa, N., Kazeto, Y., Takatsuka, N., Kato, E., Hagihara, S., Ozaki, Y., Adachi, S., Yamauchi, K., et al. (2016) · Endocrinology · doi:10.1210/en.2016-1349 · Cited by 17 · see citing works

Integrated assessment of endocrine disrupting potential of four novel brominated flame retardants

Zhang, Q., Gu, S., Chang, Y., Cao, R., Xu, Y., Fu, L., & Wang, C. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113206 · Cited by 17 · see citing works

Ovarian Endocrinology

Takae, S., & Suzuki, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-53454-1_1 · Cited by 17 · see citing works

Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis

Tang, S., Zhang, J., Mei, T., Zhang, W., Zheng, S.-J., & Yu, H. (2021) · BMC Gastroenterology · doi:10.1186/s12876-021-02067-y · Cited by 16 · see citing works

Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review

Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 16 · see citing works

A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer

Seibert, J., Quagliata, L., Quintavalle, C., Hammond, T. G., Terracciano, L., & Odermatt, A. (2015) · Cancer Medicine · doi:10.1002/cam4.517 · Cited by 16 · see citing works

Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activity

Maltais, R., Trottier, A., Barbeau, X., Lagüe, P., Perreault, M., Thériault, J.-F., Lin, S., & Poirier, D. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.10.020 · Cited by 16 · see citing works

Comparative investigation of thein vitroinhibitory potencies of 13-epimeric estrones and D-secoestrones towards 17β-hydroxysteroid dehydrogenase type 1

Herman, B. E., Szabó, J., Bacsa, I., Woelfling, J., Schneider, G., Bálint, M., Hetényi, C., Mernyák, E., & Szécsi, M. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1204610 · Cited by 16 · see citing works

Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome

(PPR), E. P. O. P. P. P. A. T. R., Hernández, A. F., Adriaanse, P., Aldrich, A., Berny, P. J., Čoja, T., Duquesne, S., Focks, A., Millet, M., Pelkonen, O., et al. (2023) · EFSA Journal · doi:10.2903/j.efsa.2023.7744 · Cited by 16 · see citing works

Design and validation of specific inhibitors of 17 -hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis

Day, J. M., Tutill, H. J., Purohit, A., & Reed, M. J. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0042 · Cited by 123 · see citing works

Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009788680000 · Cited by 57 · see citing works

Inhibitors of 17β-Hydroxysteroid Dehydrogenases

Poirier, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033368222 · Cited by 177 · see citing works

Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors

Poirier, D. (2024) · Steroids · doi:10.1016/j.steroids.2024.109529 · Cited by 12 · see citing works

Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseases

Poirier, D. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.12.007 · Cited by 44 · see citing works